MX2009006920A - Indoles. - Google Patents
Indoles.Info
- Publication number
- MX2009006920A MX2009006920A MX2009006920A MX2009006920A MX2009006920A MX 2009006920 A MX2009006920 A MX 2009006920A MX 2009006920 A MX2009006920 A MX 2009006920A MX 2009006920 A MX2009006920 A MX 2009006920A MX 2009006920 A MX2009006920 A MX 2009006920A
- Authority
- MX
- Mexico
- Prior art keywords
- present
- concerned
- compounds
- indoles
- benzopyrrolone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
La presente invención se refiere a nuevos derivados de indol-3-il-carbonil-piperidina-benzopirrolona, -benzoxazolona y -benzotriazol como antagonistas del receptor de V1a, a su obtención, a composiciones farmacéuticas que los contienen y a su utilización como medicamentos. Los compuestos activos de presente invención son útiles para la prevención y/o el tratamiento de ansiedad, trastornos depresivos y otras enfermedades. En particular, la presente invención se refiere a compuestos de fórmula general (I) (ver fórmula (I)) en donde X, Y y de R1 a R'° tienen los significados definidos en la descripción.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06127307 | 2006-12-28 | ||
PCT/EP2007/064176 WO2008080842A1 (en) | 2006-12-28 | 2007-12-19 | Indoles |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009006920A true MX2009006920A (es) | 2009-07-06 |
Family
ID=39198190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009006920A MX2009006920A (es) | 2006-12-28 | 2007-12-19 | Indoles. |
Country Status (18)
Country | Link |
---|---|
US (3) | US20080167344A1 (es) |
EP (1) | EP2125785B1 (es) |
JP (1) | JP2010514726A (es) |
KR (1) | KR101134255B1 (es) |
CN (1) | CN101583609A (es) |
AR (1) | AR064546A1 (es) |
AT (1) | ATE533760T1 (es) |
AU (1) | AU2007341377B2 (es) |
BR (1) | BRPI0720968A2 (es) |
CA (1) | CA2674133A1 (es) |
CL (1) | CL2007003831A1 (es) |
ES (1) | ES2375520T3 (es) |
MX (1) | MX2009006920A (es) |
NO (1) | NO20092356L (es) |
PE (1) | PE20081401A1 (es) |
RU (1) | RU2009124111A (es) |
TW (1) | TWI345468B (es) |
WO (1) | WO2008080842A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010093578A1 (en) * | 2009-02-10 | 2010-08-19 | Glaxo Group Limited | Indolinyl-, benzofuranyl-, and benzothienyl- amides as modulators of chemokine receptors |
AU2016348493B2 (en) * | 2015-11-06 | 2021-02-25 | F. Hoffmann-La Roche Ag | Indolin-2-one derivatives |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5686624A (en) * | 1992-01-30 | 1997-11-11 | Sanofi | 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
DE69430483D1 (de) * | 1993-07-16 | 2002-05-29 | Merck & Co Inc | Benzoxazinon- und Benzopyrimidinon- piperidinyl-Verbindungen als tokolytische Oxytocin-Rezeptor-Antagonisten |
JPH0920779A (ja) * | 1995-05-01 | 1997-01-21 | Japan Tobacco Inc | 縮合ヘテロ5員環アゼピン化合物類及びその医薬用途 |
JP2008539220A (ja) * | 2005-04-26 | 2008-11-13 | ファイザー・リミテッド | バソプレシンアンタゴニストとしてのトリアゾール誘導体 |
ES2314941T3 (es) | 2005-07-21 | 2009-03-16 | F. Hoffmann-La Roche Ag | Derivados indol-3-il-carbonil-piperidin-benzoimidazol como antagonistas del receptor via. |
EP1917255A2 (en) | 2005-07-29 | 2008-05-07 | F. Hoffmann-Roche AG | Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
US20080139617A1 (en) * | 2006-12-08 | 2008-06-12 | Caterina Bissantz | Indoles |
-
2007
- 2007-12-14 PE PE2007001813A patent/PE20081401A1/es not_active Application Discontinuation
- 2007-12-19 KR KR1020097015736A patent/KR101134255B1/ko not_active IP Right Cessation
- 2007-12-19 AU AU2007341377A patent/AU2007341377B2/en not_active Ceased
- 2007-12-19 US US11/959,573 patent/US20080167344A1/en not_active Abandoned
- 2007-12-19 CA CA002674133A patent/CA2674133A1/en not_active Abandoned
- 2007-12-19 AT AT07857799T patent/ATE533760T1/de active
- 2007-12-19 US US11/959,545 patent/US8143281B2/en not_active Expired - Fee Related
- 2007-12-19 RU RU2009124111/04A patent/RU2009124111A/ru unknown
- 2007-12-19 EP EP07857799A patent/EP2125785B1/en not_active Not-in-force
- 2007-12-19 WO PCT/EP2007/064176 patent/WO2008080842A1/en active Application Filing
- 2007-12-19 ES ES07857799T patent/ES2375520T3/es active Active
- 2007-12-19 US US11/959,522 patent/US20080161315A1/en not_active Abandoned
- 2007-12-19 MX MX2009006920A patent/MX2009006920A/es active IP Right Grant
- 2007-12-19 JP JP2009543442A patent/JP2010514726A/ja active Pending
- 2007-12-19 CN CNA2007800488386A patent/CN101583609A/zh active Pending
- 2007-12-19 BR BRPI0720968-1A patent/BRPI0720968A2/pt not_active IP Right Cessation
- 2007-12-25 TW TW096150006A patent/TWI345468B/zh not_active IP Right Cessation
- 2007-12-27 AR ARP070105914A patent/AR064546A1/es not_active Application Discontinuation
- 2007-12-27 CL CL200703831A patent/CL2007003831A1/es unknown
-
2009
- 2009-06-19 NO NO20092356A patent/NO20092356L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2125785B1 (en) | 2011-11-16 |
BRPI0720968A2 (pt) | 2014-03-11 |
JP2010514726A (ja) | 2010-05-06 |
NO20092356L (no) | 2009-06-30 |
US20080167344A1 (en) | 2008-07-10 |
CA2674133A1 (en) | 2008-07-10 |
EP2125785A1 (en) | 2009-12-02 |
RU2009124111A (ru) | 2011-02-10 |
WO2008080842A1 (en) | 2008-07-10 |
KR20090094395A (ko) | 2009-09-04 |
ES2375520T3 (es) | 2012-03-01 |
TW200835491A (en) | 2008-09-01 |
AU2007341377B2 (en) | 2012-03-22 |
US20080161315A1 (en) | 2008-07-03 |
CN101583609A (zh) | 2009-11-18 |
PE20081401A1 (es) | 2008-10-24 |
KR101134255B1 (ko) | 2012-04-12 |
ATE533760T1 (de) | 2011-12-15 |
TWI345468B (en) | 2011-07-21 |
US20080161316A1 (en) | 2008-07-03 |
AU2007341377A1 (en) | 2008-07-10 |
CL2007003831A1 (es) | 2008-07-11 |
AR064546A1 (es) | 2009-04-08 |
US8143281B2 (en) | 2012-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009006921A (es) | Derivados azaespiro. | |
MX2009007411A (es) | Derivados de espiropiperidina-glicinamida. | |
MX2009007104A (es) | Derivados de oxindol sustituido y su uso como ligandos del receptor de vasopresina. | |
MX2009005507A (es) | Derivados de espiro-piperidina. | |
GB0625648D0 (en) | Compounds | |
TNSN08283A1 (en) | Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use | |
MX2009006540A (es) | Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides. | |
NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
MY153258A (en) | Pyrazinone derivatives and their use inthe threatment of lung diseases | |
TW200612936A (en) | Indole derivatives | |
MY147588A (en) | (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives | |
GEP20135744B (en) | Quinuclidine carbonate derivatives and medicinal compositions containing the same | |
HK1132742A1 (en) | Substituted oxindole derivative and its use as a vasopressin receptor modulator | |
MX2007011695A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
TW200700391A (en) | Pyridine-2-carboxamide derivatives as mglur5 antagonists | |
TW200806300A (en) | New therapeutic combinations for the treatment of depression | |
TW200736189A (en) | Indene derivatives, their preparation and use as medicaments | |
RS20080119A (en) | Carboxamide derivatives as muscarinic receptor antagonists | |
MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
DE602008001725D1 (de) | 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus | |
MY183111A (en) | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators | |
TW200738627A (en) | Trialkylsilyl-indoles | |
MX2009005544A (es) | Indoles. | |
MX2009006454A (es) | Derivados de espiro-piperidina. | |
MX2009005541A (es) | Indoles que actuan como antagonistas del receptor v1a. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |